Peptides
Semax
What is it?
Semax is a synthetic seven-amino-acid peptide related to a fragment of ACTH, a hormone involved in the stress response. People are interested in it for attention, memory, and mental stamina. It has been used as a nasal medicine in Russia; that registration does not make it an FDA-approved medicine in the United States. [1]
How does it work?
One proposed pathway involves BDNF, a protein involved in nerve-cell function and adaptability. In rats, Semax increased hippocampal BDNF-related signaling and improved a learning task. That gives researchers a biological reason to investigate cognition, but a rat brain response does not tell us how much a healthy person will remember or concentrate. [2]
Why is it used for focus and memory?
There is some direct human evidence, although it is small and old. A 1996 double-blind study randomly assigned 16 male power-plant operators to Semax or placebo. During two workdays, the Semax group showed less deterioration on a number-recognition task. However, spontaneous incorrect button presses did not consistently improve, and the authors discussed a possible arousing or anxiety-related effect. Eight people per group and a specific work task cannot establish a dependable everyday cognitive benefit. [3]
A 2018 randomized study compared nasal Semax with placebo in 24 healthy adults. Researchers detected changes in part of the brain's default-mode network during scans over 20 minutes. This was an imaging experiment, without a demonstrated improvement on a memory or attention test. [4]
Together, these findings justify further study. They do not establish the size, durability, or reliability of a focus benefit across healthy adults. Research in people recovering from neurological illness also answers a different question from enhancing an otherwise healthy brain.
Safety and product differences
FDA's 2026 review identifies important gaps in human safety information and concerns about formulation quality and immune reactions. Evidence from nasal products should not be treated as evidence that injections are equally safe. Products sold under the Semax name may also differ in chemical form; modified versions are not automatically interchangeable with the molecule studied. Compounding discussions are separate from FDA drug approval. [1]
ADULT STUDY AMOUNT
How much?
FORM & SCHEDULE
What it refers to
intranasal Semax in that study
Semax is not FDA-approved. Safety and product-quality gaps remain; nasal research does not establish injection safety.
1.2 mg — a single intranasal amount in an adult brain-imaging study. [4]
Read detailed dosing notes
This is research context, not a recommended focus dose or a self-treatment schedule. That experiment measured brain signals for minutes, not repeated-use benefits or long-term safety. A nasal concentration or bottle size alone also does not specify the amount delivered. [1,4]
Sources & further reading
- FDA (2026). Evaluation of Semax-related bulk drug substances (opens in a new tab)www.fda.gov
- Dolotov et al. (2006). Semax regulates BDNF and trkB expression in the rat hippocampus (opens in a new tab)doi.org
- Kaplan et al. (1996). Synthetic ACTH analogue Semax displays nootropic-like activity in humans (opens in a new tab)onlinelibrary.wiley.com
- Lebedeva et al. (2018). Effects of Semax on the default mode network of the brain (opens in a new tab)pubmed.ncbi.nlm.nih.gov